NCR2 and acute myeloid leukemia: Regarding the expression of ligands for NK cell activating receptors, our results for ULBP-1, a ligand of NKG2D, are in disagreement with those reported for AML, in which a higher expression of ULBP-1 was associated with reduced relapse and improved 2-year overall survival [70].